1451 related articles for article (PubMed ID: 29057536)
1. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
Iwasaki M; Ishihara S; Okada S; Shimegi R; Shimomura M; Inoue M
Ann Surg Oncol; 2022 Sep; 29(9):5699-5707. PubMed ID: 35653068
[TBL] [Abstract][Full Text] [Related]
4. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy.
Sun Y; Zhang Y; Huang Z; Lin H; Lu X; Huang Y; Chi P
World J Surg; 2020 Jun; 44(6):1975-1984. PubMed ID: 32020327
[TBL] [Abstract][Full Text] [Related]
5. The Combination of Plasma Fibrinogen Concentration and Neutrophil Lymphocyte Ratio (F-NLR) as a Prognostic Factor of Epithelial Ovarian Cancer.
Yang J; Ma J; Cheng S; Wang Y
Onco Targets Ther; 2020; 13():7283-7293. PubMed ID: 32848410
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
[TBL] [Abstract][Full Text] [Related]
8. Prognostic analysis of the plasma fibrinogen combined with neutrophil-to-lymphocyte ratio in patients with non-small cell lung cancer after radical resection.
Wang GX; Huang ZN; Ye YQ; Tao SM; Xu MQ; Zhang M; Xie MR
Thorac Cancer; 2023 May; 14(15):1383-1391. PubMed ID: 37037492
[TBL] [Abstract][Full Text] [Related]
9. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
Yan X; Li G
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.
Wang J; Kalhor N; Hu J; Wang B; Chu H; Zhang B; Guan Y; Wu Y
PLoS One; 2016; 11(10):e0163397. PubMed ID: 27695079
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma.
Muriana P; Carretta A; Ciriaco P; Bandiera A; Negri G
J Cardiothorac Surg; 2018 Nov; 13(1):119. PubMed ID: 30454002
[TBL] [Abstract][Full Text] [Related]
12. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
Dirican N; Karakaya YA; Gunes S; Daloglu FT; Dirican A
Clin Respir J; 2017 Nov; 11(6):789-796. PubMed ID: 26619201
[TBL] [Abstract][Full Text] [Related]
13. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
[No Abstract] [Full Text] [Related]
15. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
[TBL] [Abstract][Full Text] [Related]
16. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
Zhang LX; Wei ZJ; Xu AM; Zang JH
Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the combination of preoperative fibrinogen and the neutrophil-lymphocyte ratio in patients with non-small cell lung cancer following surgical resection.
Liang HG; Gao K; Jia R; Li J; Wang C
Oncol Lett; 2019 Feb; 17(2):1435-1444. PubMed ID: 30675197
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer.
Huang W; Wang S; Zhang H; Zhang B; Wang C
Cancer Biol Med; 2018 Feb; 15(1):88-96. PubMed ID: 29545972
[TBL] [Abstract][Full Text] [Related]
19. Combined fibrinogen and neutrophil-lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma.
Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
Cancer Manag Res; 2018; 10():6285-6294. PubMed ID: 30568490
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen and Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hypopharyngeal Squamous Cell Carcinoma.
Kuwahara T; Takahashi H; Sano D; Matsuoka M; Hyakusoku H; Hatano T; Hiiragi Y; Oridate N
Anticancer Res; 2018 Sep; 38(9):5321-5330. PubMed ID: 30194184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]